336 related articles for article (PubMed ID: 21193542)
1. Mortality and morbidity in Cushing's disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature.
Clayton RN; Raskauskiene D; Reulen RC; Jones PW
J Clin Endocrinol Metab; 2011 Mar; 96(3):632-42. PubMed ID: 21193542
[TBL] [Abstract][Full Text] [Related]
2. Mortality in Cushing's disease.
Clayton RN
Neuroendocrinology; 2010; 92 Suppl 1():71-6. PubMed ID: 20829622
[TBL] [Abstract][Full Text] [Related]
3. Surviving ectopic Cushing's syndrome: quality of life, cardiovascular and metabolic outcomes in comparison to Cushing's disease during long-term follow-up.
Osswald A; Deutschbein T; Berr CM; Plomer E; Mickisch A; Ritzel K; Schopohl J; Beuschlein F; Fassnacht M; Hahner S; Reincke M
Eur J Endocrinol; 2018 Aug; 179(2):109-116. PubMed ID: 29875286
[TBL] [Abstract][Full Text] [Related]
4. Outcome of Cushing's disease following transsphenoidal surgery in a single center over 20 years.
Hassan-Smith ZK; Sherlock M; Reulen RC; Arlt W; Ayuk J; Toogood AA; Cooper MS; Johnson AP; Stewart PM
J Clin Endocrinol Metab; 2012 Apr; 97(4):1194-201. PubMed ID: 22278423
[TBL] [Abstract][Full Text] [Related]
5. Mortality in patients treated for Cushing's disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma.
Dekkers OM; Biermasz NR; Pereira AM; Roelfsema F; van Aken MO; Voormolen JH; Romijn JA
J Clin Endocrinol Metab; 2007 Mar; 92(3):976-81. PubMed ID: 17200171
[TBL] [Abstract][Full Text] [Related]
6. Predictors of mortality and long-term outcomes in treated Cushing's disease: a study of 346 patients.
Lambert JK; Goldberg L; Fayngold S; Kostadinov J; Post KD; Geer EB
J Clin Endocrinol Metab; 2013 Mar; 98(3):1022-30. PubMed ID: 23393167
[TBL] [Abstract][Full Text] [Related]
7. Diabetes, Active Disease, and Afternoon Serum Cortisol Levels Predict Cushing's Disease Mortality: A Cohort Study.
Roldán-Sarmiento P; Lam-Chung CE; Hinojosa-Amaya JM; Morales-García M; Guillén-Placencia MF; Pérez-Flores GE; León-Suárez A; León-Domínguez J; Balbuena-Álvarez S; Nava de la Vega A; Pérez-Guzmán CM; Gómez-Sámano MÁ; Enríquez-Estrada V; Gómez-Pérez FJ; Cuevas-Ramos D
J Clin Endocrinol Metab; 2021 Jan; 106(1):e103-e111. PubMed ID: 33108798
[TBL] [Abstract][Full Text] [Related]
8. Mortality in Cushing's syndrome: systematic analysis of a large series with prolonged follow-up.
Ntali G; Asimakopoulou A; Siamatras T; Komninos J; Vassiliadi D; Tzanela M; Tsagarakis S; Grossman AB; Wass JA; Karavitaki N
Eur J Endocrinol; 2013 Nov; 169(5):715-23. PubMed ID: 23996696
[TBL] [Abstract][Full Text] [Related]
9. Comorbidities in Cushing's disease.
Sharma ST; Nieman LK; Feelders RA
Pituitary; 2015 Apr; 18(2):188-94. PubMed ID: 25724314
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology and mortality of Cushing's syndrome.
Hakami OA; Ahmed S; Karavitaki N
Best Pract Res Clin Endocrinol Metab; 2021 Jan; 35(1):101521. PubMed ID: 33766428
[TBL] [Abstract][Full Text] [Related]
11. Transsphenoidal microsurgery for Cushing's disease: initial outcome and long-term results.
Hammer GD; Tyrrell JB; Lamborn KR; Applebury CB; Hannegan ET; Bell S; Rahl R; Lu A; Wilson CB
J Clin Endocrinol Metab; 2004 Dec; 89(12):6348-57. PubMed ID: 15579802
[TBL] [Abstract][Full Text] [Related]
12. Management of endocrine disease: Mortality remains increased in Cushing's disease despite biochemical remission: a systematic review and meta-analysis.
van Haalen FM; Broersen LH; Jorgensen JO; Pereira AM; Dekkers OM
Eur J Endocrinol; 2015 Apr; 172(4):R143-9. PubMed ID: 25722097
[TBL] [Abstract][Full Text] [Related]
13. Effect of primary empty sella syndrome on pituitary surgery for Cushing's disease.
Mehta GU; Bakhtian KD; Oldfield EH
J Neurosurg; 2014 Sep; 121(3):518-26. PubMed ID: 24857241
[TBL] [Abstract][Full Text] [Related]
14. Complications and mortality of Cushing's disease: report on data collected over a 20-year period at a referral centre.
Mondin A; Ceccato F; Voltan G; Mazzeo P; Manara R; Denaro L; Scaroni C; Barbot M
Pituitary; 2023 Oct; 26(5):551-560. PubMed ID: 37495935
[TBL] [Abstract][Full Text] [Related]
15. Complications after transsphenoidal surgery for patients with Cushing's disease and silent corticotroph adenomas.
Smith TR; Hulou MM; Huang KT; Nery B; de Moura SM; Cote DJ; Laws ER
Neurosurg Focus; 2015 Feb; 38(2):E12. PubMed ID: 25639314
[TBL] [Abstract][Full Text] [Related]
16. Surgical remission of pituitary adenomas confined to the neurohypophysis in Cushing's disease.
Weil RJ; Vortmeyer AO; Nieman LK; Devroom HL; Wanebo J; Oldfield EH
J Clin Endocrinol Metab; 2006 Jul; 91(7):2656-64. PubMed ID: 16636117
[TBL] [Abstract][Full Text] [Related]
17. Metabolic and cardiovascular outcomes in patients with Cushing's syndrome of different aetiologies during active disease and 1 year after remission.
Giordano R; Picu A; Marinazzo E; D'Angelo V; Berardelli R; Karamouzis I; Forno D; Zinnà D; Maccario M; Ghigo E; Arvat E
Clin Endocrinol (Oxf); 2011 Sep; 75(3):354-60. PubMed ID: 21521323
[TBL] [Abstract][Full Text] [Related]
18. Surgical management of adrenocorticotropic hormone-secreting macroadenomas: outcome and challenges in patients with Cushing's disease or Nelson's syndrome.
De Tommasi C; Vance ML; Okonkwo DO; Diallo A; Laws ER
J Neurosurg; 2005 Nov; 103(5):825-30. PubMed ID: 16304985
[TBL] [Abstract][Full Text] [Related]
19. Cushing's disease: results of treatment and factors affecting outcome.
Ammini AC; Bhattacharya S; Sahoo JP; Philip J; Tandon N; Goswami R; Jyotsna VJ; Khadgawat R; Chumber S; Seth A; Karak AK; Sharma BS; Chandra PS; Suri A; Sharma MS; Kale SS; Singh M
Hormones (Athens); 2011; 10(3):222-9. PubMed ID: 22001133
[TBL] [Abstract][Full Text] [Related]
20. Mortality in patients with Cushing's disease more than 10 years after remission: a multicentre, multinational, retrospective cohort study.
Clayton RN; Jones PW; Reulen RC; Stewart PM; Hassan-Smith ZK; Ntali G; Karavitaki N; Dekkers OM; Pereira AM; Bolland M; Holdaway I; Lindholm J
Lancet Diabetes Endocrinol; 2016 Jul; 4(7):569-76. PubMed ID: 27265184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
